These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27134162)

  • 1. Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a.
    Haney SL; Upchurch GM; Opavska J; Klinkebiel D; Hlady RA; Suresh A; Pirruccello SJ; Shukla V; Lu R; Costinean S; Rizzino A; Karpf AR; Joshi S; Swanson P; Opavsky R
    Cell Rep; 2016 May; 15(6):1190-201. PubMed ID: 27134162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.
    Haney SL; Hlady RA; Opavska J; Klinkebiel D; Pirruccello SJ; Dutta S; Datta K; Simpson MA; Wu L; Opavsky R
    Oncogene; 2015 Oct; 34(43):5436-5446. PubMed ID: 25639876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice.
    Haney SL; Upchurch GM; Opavska J; Klinkebiel D; Appiah AK; Smith LM; Heavican TB; Iqbal J; Joshi S; Opavsky R
    Sci Rep; 2016 Sep; 6():34222. PubMed ID: 27677595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.
    Gray KS; Forrest JC; Speck SH
    J Virol; 2010 May; 84(10):4946-59. PubMed ID: 20200245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma.
    Haney SL; Upchurch GM; Opavska J; Klinkebiel D; Hlady RA; Roy S; Dutta S; Datta K; Opavsky R
    PLoS Genet; 2016 Sep; 12(9):e1006334. PubMed ID: 27690235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of
    Biran A; Yin S; Kretzmer H; Ten Hacken E; Parvin S; Lucas F; Uduman M; Gutierrez C; Dangle N; Billington L; Regis FF; Rassenti LZ; Mohammad A; Hoffmann GB; Stevenson K; Zheng M; Witten E; Fernandes SM; Tausch E; Sun C; Stilgenbauer S; Brown JR; Kipps TJ; Aster JC; Gnirke A; Neuberg DS; Letai A; Wang L; Carrasco RD; Meissner A; Wu CJ
    Cancer Res; 2021 Dec; 81(24):6117-6130. PubMed ID: 34686499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
    Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R
    J Biol Chem; 2021; 296():100285. PubMed ID: 33450231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
    Huang D; Ovcharenko I
    BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development.
    Lu R; Wang P; Parton T; Zhou Y; Chrysovergis K; Rockowitz S; Chen WY; Abdel-Wahab O; Wade PA; Zheng D; Wang GG
    Cancer Cell; 2016 Jul; 30(1):92-107. PubMed ID: 27344947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
    Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
    J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.
    Tang YA; Lin RK; Tsai YT; Hsu HS; Yang YC; Chen CY; Wang YC
    Clin Cancer Res; 2012 Aug; 18(16):4325-33. PubMed ID: 22733537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of DNA methylation activity through Dnmt3L promoter methylation by Dnmt3 enzymes in embryonic development.
    Hu YG; Hirasawa R; Hu JL; Hata K; Li CL; Jin Y; Chen T; Li E; Rigolet M; Viegas-Péquignot E; Sasaki H; Xu GL
    Hum Mol Genet; 2008 Sep; 17(17):2654-64. PubMed ID: 18544626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering the DNA methylome in chronic lymphocytic leukemia.
    Cahill N; Rosenquist R
    Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of DNA methyltransferase 3a in obese adipose tissue: studies with transgenic mice.
    Kamei Y; Suganami T; Ehara T; Kanai S; Hayashi K; Yamamoto Y; Miura S; Ezaki O; Okano M; Ogawa Y
    Obesity (Silver Spring); 2010 Feb; 18(2):314-21. PubMed ID: 19680236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Myocyte De Novo DNA Methyltransferases 3a/3b Are Dispensable for Cardiac Function and Remodeling after Chronic Pressure Overload in Mice.
    Nührenberg TG; Hammann N; Schnick T; Preißl S; Witten A; Stoll M; Gilsbach R; Neumann FJ; Hein L
    PLoS One; 2015; 10(6):e0131019. PubMed ID: 26098432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.
    Mayle A; Yang L; Rodriguez B; Zhou T; Chang E; Curry CV; Challen GA; Li W; Wheeler D; Rebel VI; Goodell MA
    Blood; 2015 Jan; 125(4):629-38. PubMed ID: 25416277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
    Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
    Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.
    Martinelli S; Kanduri M; Maffei R; Fiorcari S; Bulgarelli J; Marasca R; Rosenquist R
    Epigenetics; 2013 Jul; 8(7):720-9. PubMed ID: 23803577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.